Cooperative action of JNK and AKT/mTOR in 1-methyl-4-phenylpyridinium-induced autophagy of neuronal PC12 cells

Journal of Neuroscience Research

Volumn 90, Issue 9, 2012, Pages 1850-1860

  Rodríguez Blanco, Jezabel ^a   Martín, Vanesa ^a,b   García Santos, Guillermo ^a,b   Herrera, Federico ^a,b   Casado Zapico, Sara ^a,b   Antolín, Isaac ^a,b   Rodriguez, Carmen ^a,b  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

AKT; Autophagy; JNK; MPP+; Neuronal PC12; Oxidative stress

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BECLIN 1; CASPASE 3; MAMMALIAN TARGET OF RAPAMYCIN; OXIDIZING AGENT; PEROXIDE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL STRAIN; CELL SURVIVAL; CELL VACUOLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; MAP KINASE KINASE 4; NEURONS; NEUROTOXINS; OXIDATIVE STRESS; PC12 CELLS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84863776849     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23066     Document Type: Article

References (56)

1. Abeliovich H, Dunn WA Jr, Kim J, Klionsky DJ. 2000. Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol 151: 1025-12034.
2. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494.
3. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, Ischiropoulos H. 1998. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Proc Natl Acad Sci U S A 95: 7659-7663.
4. Bao JF, Wu RG, Zhang XP, Song Y, Li CL. 2005. Melatonin attenuates 1-methyl-4-phenylpyridinium-induced PC12 cell death. Acta Pharmacol Sin 26: 117-123.
5. Bennett BL, Sasaki DT, Murray BW, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98: 13681-13686.
6. Biswas SC, Greene LA. 2002. Nerve growth factor (NGF) downregulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation. J Biol Chem 277: 49511-49516.
7. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM. 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65: 135-172.
8. Brunet A, Datta SR, Greenberg ME. 2001. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11: 297-305.
9. Bruno P, Calastretti A, Priulla M, Asnaghi L, Scarlatti F, Nicolin A, Canti G. 2007. Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles. Cell Signal 19: 2118-2126.
10. Codogno P, Meijer AJ. 2005. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 12( Suppl 2): 1509-1518.
11. Conde S, Pérez DI, Martínez A, Perez C, Moreno FJ. 2003. Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching. J Med Chem 46: 4631-4633.
12. Cross DAE, Culbert AA, Chalmers KA, et al. 2001. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurons from death. J Neurochem 77: 94-102.
13. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. 2004. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305: 1292-1295.
14. Dagda RK, Cherra SJ3rd, Kulich SM, Tandon A, Park D, Chu CT. 2009. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284: 13843-13855.
15. Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ. 1979. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1: 249-254.
16. Denizot F, Lang R. 1986. Rapid colorimetric assay for cell growth and survival. J Inmunol Methods 89: 271-277.
17. Eminel S, Klettner A, Roemer L, Herdegen T, Waetzig V. 2004. JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine. J Biol Chem 279: 55385-55392.
18. +-induced apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res 55: 620.
19. Fariello RG. 1988. Experimental support for the implication of oxidative stress in the genesis of parkinsonian syndromes. Funct Neurol 3: 407-412.
20. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247.
21. 2+ release from mitochondria. FEBS Lett 198: 99-102.
22. Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. 2008. To die or not to die: that is the autophagic question. Curr Mol Med 8: 78-91.
23. Gibrat C, Saint-Pierre M, Bousquet M, Lévesque D, Rouillard C, Cicchetti F. 2009. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. J Neurochem 109: 1469-1482.
24. 2. Regulation of reactive oxygen species levels by phosphatidylinositol 3-kinase. J Biol Chem 276: 46379-46385.
25. Harman D. 1981. The aging process. Proc Natl Acad Sci U S A 78: 7124-7128.
26. +, a possible parkinsonism inducer, on dopamine content and tyrosine hydroxylase mRNA expression in PC12 cells. Neurochem Int 26: 165-171.
27. Jenner P, Schapira AH, Marsden CD. 1992. New insights into the cause of Parkinson's disease. Neurology 42: 2241-2250.
28. Jia G, Cheng G, Gangahar DM, Agrawal DK. 2006. Insulin-like growth factor-1 and TNF-alpha regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells. Immunol Cell Biol 84: 448.
29. Jiang H, Gomez-Manzano C, Aoki H, Alonso MM, Kondo S, McCormick F, Xu J, Kondo Y, Bekele BN, Colman H, Lang FF, Fueyo J. 2007. Examination of the therapeutic potential of delta-24-RGD in brain tumor stem cells: role of autophagic cell death. JNCI 99: 1410-1414.
30. Junn E, Mouradian MM. 2001. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J Neurochem 78: 374-383.
31. Kilic U, Kilic E, Järve A, Guo Z, Spudich A, Bieber K, Barzena U, Bassetti CL, Marti HH, Hermann DM. 2006. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci 26: 12439-12446.
32. Kim EH, Sohn S, Kwon HJ, Kim SU, Kim MJ, Lee SJ, Choi KS. 2007. Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res 67: 6314-6324.
33. + toxicity and oxidative stress in neonatal animals. Brain Res 713: 178-185.
34. Lee JA. 2009. Autophagy in neurodegeneration: two sides of the same coin. BMB Rep 42: 324-330.
35. Li W, Zhang J, Flechner L, Hyun T, Yam A, Franke F, Pierce JH. 1999. Protein kinase C overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal. Oncogene 18: 6564-6572.
36. Liu WS, Heckman CA. 1998. The sevenfold way of PKC regulation. Cell Signal 10: 529-542.
37. Malagelada C, Ryu EJ, Biswas SC, Jackson-Lewis V, Greene LA. 2006. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci 26: 9996-10005.
38. Mochizuki H, Goto K, Mori H, Mizuno Y. 1996. Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 137: 120-123.
39. Morimoto N, Nagai M, Ohta Y, Miyazaki K, Kurata T, Morimoto M, Murakami T, Takehisa Y, Ikeda Y, Kamiya T, Abe K. 2007. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res 1167: 112-117.
40. Nemoto S, Xiang J, Huang S, Lin A. 1998. Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J Biol Chem 273: 16415-16420.
41. Pantano C, Shrivastava P, McElhinney B, Janssen-Heininger Y. 2003. Hydrogen peroxide signaling through tumor necrosis factor receptor 1 leads to selective activation of c-Jun N-terminal kinase. J Biol Chem 278: 44091-44096.
42. Peng J, Andersen JK. 2003. The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease. IUBMB Life 55: 267-271.
43. Rodriguez-Blanco J, Martín V, Herrera F, García-Santos G, Antolín I, Rodriguez C. 2008. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine. J Neurochem 107: 127-140.
44. Rubinsztein DC, DiFiglia M, Heintz N, Nixon RA, Qin ZH, Ravikumar B, Stefanis L, Tolkovsky A. 2005. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 1: 11-22.
45. Saito A, Narasimhan P, Hayashi T, Okuno S, Ferrand-Drake M, Chan PH. 2004. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. J Neurosci 24: 1584-1593.
46. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. 2007. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749-1760.
47. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, Tsujimoto Y. 2004. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6: 1221-1228.
48. Sonoda Y, Watanabe S, Matsumoto Y, Aizu-Yokota E, Kasahara T. 1999. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem 274: 10566-10570.
49. Todde V, Veenhuis M, van der Klei IJ. 2009. Autophagy: principles and significance in health and disease. Biochim Biophys Acta 1792: 3-13.
50. Vyas I, Heikkila RE, Nicklas WJ. 1986. Studies on the neurotoxicity of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium. J Neurochem 46: 1501-1507.
51. Wang H, Joseph JA. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27: 612-616.
52. Wei Y, Sinha S, Levine B. 2008. Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation. Autophagy 4: 949-951.
53. Welcker M, Clurman BE. 2008. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8: 83-93.
54. +: selective vulnerability of cultured mouse astrocytes. Brain Res 836: 237-244.
55. Xilouri M, Stefanis L. 2011. Autophagic pathways in Parkinson disease and related disorders. Expert Rev Mol Med 13: e8.
56. Xue L, Fletcher GC, Tolkovsky AM. 1999. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 14: 180-198.